Impact of camel milk lactoferrin peptides against breast cancer cells: in silico and in vitro study
Camel milk-derived lactoferrin peptides show promise as anticancer agents against breast cancer cells. The multidisciplinary approach employed in this study provides valuable insights into the mechanisms underlying their activity, paving the way for rational design strategies to enhance their efficacy. Further experimental validation is warranted to validate the anticancer potential of these peptides and advance their development as novel therapeutic agents for breast cancer treatment.
Authors
- Hisham N. Altayb (ORCID: https://orcid.org/0000-0002-2635-9383)
- Emadeldin Hassan E. Konozy (ORCID: https://orcid.org/0000-0001-9478-8633)
- Ehab M. M. Ali
- Hassan I. Alguridi
- Abrar Ahmad (ORCID: https://orcid.org/0000-0002-6308-952X)
- Salman Hosawi (ORCID: https://orcid.org/0000-0002-0639-1618)
- Isam M. Abu Zeid (ORCID: https://orcid.org/0000-0002-1355-231X)
- Othman A. Baothman (ORCID: https://orcid.org/0000-0002-3286-4669)
Institutions
- University of Cape Coast (GH)
- King Abdulaziz University (SA)
- Tanta University (EG)
- University of Garden City (SD)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-19
- DOI
- https://doi.org/10.3389/fphar.2024.1425504
- Citations
- 6
- Primary Topic
- Animal Diversity and Health Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- King Abdulaziz University